Crystallization of the Multi-Receptor Tyrosine Kinase Inhibitor Sorafenib for Controlled Long-Term Drug Delivery Following a Single Injection.
Victoria LaiSarah Y NeshatAmanda RakoskiJames PitingoloJohndavid SabedraStephen LiAryaman ShodhanJoshua C DoloffPublished in: Cellular and molecular bioengineering (2021)
The online version contains supplementary material available at 10.1007/s12195-021-00708-6.